7.66
Precision Biosciences Inc stock is traded at $7.66, with a volume of 297.67K.
It is up +5.95% in the last 24 hours and up +35.10% over the past month.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
See More
Previous Close:
$7.23
Open:
$7.3
24h Volume:
297.67K
Relative Volume:
1.11
Market Cap:
$197.65M
Revenue:
$34.26M
Net Income/Loss:
$-46.61M
P/E Ratio:
-1.4786
EPS:
-5.1806
Net Cash Flow:
$-62.01M
1W Performance:
+27.88%
1M Performance:
+35.10%
6M Performance:
+17.85%
1Y Performance:
+38.77%
Precision Biosciences Inc Stock (DTIL) Company Profile
Name
Precision Biosciences Inc
Sector
Industry
Phone
919-314-5512
Address
302 EAST PETTIGREW STREET, DURHAM, NC
Compare DTIL vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DTIL
Precision Biosciences Inc
|
7.66 | 186.56M | 34.26M | -46.61M | -62.01M | -5.1806 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-30-24 | Initiated | Guggenheim | Buy |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Jun-09-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-27-20 | Resumed | BTIG Research | Buy |
| Apr-03-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-05-20 | Initiated | Stifel | Buy |
| Feb-25-20 | Initiated | William Blair | Outperform |
| Aug-09-19 | Initiated | BTIG Research | Buy |
| Jul-16-19 | Initiated | H.C. Wainwright | Buy |
| Apr-22-19 | Initiated | Barclays | Overweight |
| Apr-22-19 | Initiated | Goldman | Buy |
| Apr-22-19 | Initiated | JP Morgan | Overweight |
| Apr-22-19 | Initiated | Jefferies | Buy |
View All
Precision Biosciences Inc Stock (DTIL) Latest News
Precision BioSciences (DTIL) surpasses Q4 earnings and revenue estimates - MSN
Precision BioSciences Expands ELIMINATE-B Trial to Europe - National Today
Precision BioSciences (DTIL) Expands Hepatitis B Trial to Europe - GuruFocus
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries - BioSpace
Empery Asset Management, Ryan M. Lane (DTIL) disclose 7.63% ownership - Stock Titan
Precision BioSciences reports encouraging muscle improvements in preclinical DMD gene therapy study - MSN
Should You Buy Precision BioSciences (DTIL) After Golden Cross? - Yahoo Finance
DTIL Options Volatility — NASDAQ:DTIL - TradingView — Track All Markets
DTIL Options Chain — NASDAQ:DTIL - TradingView — Track All Markets
Jobs Data: How does Precision BioSciences Inc compare to its peersStock Surge & Verified High Yield Trade Plans - baoquankhu1.vn
How does Precision BioSciences Inc compare to its peersWeekly Market Summary & AI Forecasted Stock Moves - baoquankhu1.vn
DTIL Price Today: Precision BioSciences, Inc. Stock Price, Quote & Chart - MEXC
Precision BioSciences to Attend Healthcare Conference - National Today
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference - BioSpace
Precision BioSciences (NASDAQ: DTIL) details equity plan, charter change in 2026 proxy - Stock Titan
DTIL Stock Price, Quote & Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill
DTIL Stock Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill
Precision BioSciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Precision Biosciences Shares Face Significant Pressure Amid Market Skepticism () - aktiencheck.de
Quarterly Recap: What is the long term forecast for Precision BioSciences Inc stockExit Point & AI Forecast for Swing Trade Picks - baoquankhu1.vn
FOMO Trade: How does Precision BioSciences Inc perform in inflationary periodsPortfolio Return Report & AI Based Trade Execution Alerts - baoquankhu1.vn
Aug Action: Is Precision BioSciences Inc stock trending bullishInsider Buying & Expert Curated Trade Ideas - baoquankhu1.vn
3.8M-share increase, director elections and charter change at Precision BioSciences (NASDAQ: DTIL) - Stock Titan
Will Precision BioSciences Inc be affected by tariffs2026 Biggest Moves & Growth Focused Entry Point Reports - baoquankhu1.vn
VIX Spike: How does Precision BioSciences Inc compare to its peersQuarterly Risk Review & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Decliners Report: Is Rafael Holdings Inc Equity Warrant stock a good dividend stockProduct Launch & Safe Swing Trade Setups - baoquankhu1.vn
Meme Stocks: What is the PEG ratio of Precision BioSciences Inc2026 Opening Moves & Risk Managed Investment Strategies - baoquankhu1.vn
Precision BioSciences (DTIL) Expected to Announce Earnings on Tuesday - MarketBeat
Q1 EPS Estimate for Precision BioSciences Raised by Analyst - MarketBeat
If You Invested $1,000 in Precision Biosciences (DTIL) - Stock Titan
Growth Value: How does Precision BioSciences Inc compare to its peers2026 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn
Brokers Set Expectations for DTIL Q1 Earnings - MarketBeat
ETFs Investing in Precision BioSciences, Inc. Stocks - TradingView
Portfolio Recap: Is Precision BioSciences Inc likely to announce a buybackTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn
Precision BioSciences, Inc. (DTIL) Shareholder/Analyst CallSlideshow (NASDAQ:DTIL) 2026-03-18 - Seeking Alpha
Jones Trading reiterates Precision BioSciences stock rating on DMD trial design - Investing.com Canada
Jones Trading reiterates Precision BioSciences stock rating on DMD trial design By Investing.com - Investing.com South Africa
FDA puts infant gene therapy ECUR-506 in rare CMC pilot to speed manufacturing talks - Stock Titan
Precision BioSciences Announces PBGENE-DMD Investor Update and Highlights ARCUS Gene Editing Platform – March 2026 - Minichart
Precision BioSciences Highlights PBGENE-DMD Program and Trial - TipRanks
PBGENE-DMD gene editing strategy at Precision BioSciences (NASDAQ: DTIL) - Stock Titan
Quarterly Risk: How volatile is Precision BioSciences Inc stockEarnings Overview Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Precision BioSciences (DTIL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Precision BioSciences Stock (ISIN: US74019P1084) Surges on Q4 Profit Turnaround Amid Analyst Upgrade - AD HOC NEWS
Jefferies cuts Precision BioSciences stock price target on valuation - Investing.com India
Precision BioSciences (NASDAQ:DTIL) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Precision BioSciences (DTIL) Q4 Profit Of US$19.2m Challenges Ongoing Loss Narrative - simplywall.st
Precision BioSciences Inc buy Jefferies Financial Group Inc. - sharewise.com
Jefferies cuts Precision BioSciences stock price target on valuation By Investing.com - Investing.com Australia
DTIL SEC FilingsPrecision Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan
Precision BioSciences Advances PBGENE-DMD Trial, Putting New Focus on Duchenne Gene Therapy - TipRanks
Precision Biosciences Inc Stock (DTIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):